AI assistant
Sending…
Moberg Pharma — Major Shareholding Notification 2021
Aug 11, 2021
3174_iss_2021-08-11_9f9dc48a-5aa6-458a-9dc2-74dd8191213c.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer

Issuer Moberg Pharma AB (publ)
Holder
Nordnet AB (publ)
Instrument
| Instrument | Aktier SE0013121340 |
|---|---|
| Before the transaction | |
| Shares | 2,255,416 |
| Voting rights | 2,255,416 |
| Transaction | |
| Date | 10/08/2021 |
| Limit for number of shares 5 % | |
| Limit for number of votes | 5 % |
| After the transaction | |
| Quantity | |
| Shares | 2,277,327 |
Directly held voting rights 0 Indirectly held voting rights 2,277,327 Percentage Directly held shares 5 %
Directly held voting rights 0 % Indirectly held voting rights 5 %
Resulting distribution of total
| holdings | ||
|---|---|---|
| Percentage of voting rights: |
Number of underlying shares: |
|
| Shares | 5 % | 2,277,327 |
| Instruments - FITA Ch. 4, section 2, first paragraph, line 2 |
||
| Instruments - FITA Ch. 4, section 2, first paragraph, line 3 |
||
| - Physically settled | ||
| - Cash settled | ||
| Total | 5 % | 2,277,327 |
| Chain of controlling companies Voting rights % Voting rights Company |
| 2,061,193 4.53 | Nordnet Pensionsförsäkring AB | ||
|---|---|---|---|
| 216,134 | 0.47 | Nordnet Livsforsikring AS | |
| Group total holdings |
|||
| Voting rights | 2,277,327 | ||
| Percentage of voting rights 5 |
Notes (other relevant informations according to law)
Nordnet AB (publ) genom Nordnet Pensionsförsäkring AB och Nordnet Livsforsikring AS har överskridit tröskelvärdet 5% av antalet utestående aktier och röster till följd av nettoköp i Moberg Pharma AB.
Published
11/08/2021 13:20
Contact
Name Niklas Matses Phone 0733854156 Email [email protected]

[email protected] Tfn 08-408 980 37 Fax 08-24 39 25
More from Moberg Pharma
Declaration of Voting Results & Voting Rights Announcements
2026
May 21
Declaration of Voting Results & Voting Rights Announcements
2026
May 21
Interim / Quarterly Report
2026
May 12
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
Apr 24
Regulatory Filings
2026
Apr 24
Proxy Solicitation & Information Statement
2026
Apr 17
AGM Information
2026
Apr 17
Annual Report
2026
Apr 17
Regulatory Filings
2026
Mar 13